Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2017 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2017 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway

  • Authors:
    • Yujie He
    • Jie Fang
    • Chong Zhang
    • Jun Pan
    • Qi Jin
    • Yingzhi Yang
    • Linyao Wang
    • Baoming Wang
    • Dayong Zhang
    • Jianping Pan
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China, Cancer Institute, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310007, P.R. China
  • Pages: 3528-3534
    |
    Published online on: July 17, 2017
       https://doi.org/10.3892/mmr.2017.7021
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Pyelonephritis is an infection of the upper urinary tract with characteristic histological change to neutrophil infiltration in the kidney. The majority of pyelonephritis is caused by uropathogenic Escherichia (E.) coli (UPEC) bearing distinct virulence factors. Toll/interleukin‑1 receptor domain‑containing protein C (TcpC) encoded by E. coli is an important virulence factor in the majority of strains of UPEC and inhibits macrophage‑mediated innate immunity, which serves an essential role in the pathogenesis of pyelonephritis. In the present study, it was demonstrated that TcpC induced kidney cells to produce macrophage inflammatory protein‑2 (MIP‑2; also known as C‑X‑C motif chemokine 2). MIP‑2 concentration in kidney homogenates from TcpC‑secreting UPEC CFT073 (TcpCwt) murine pyelonephritis models was significantly higher compared with that in kidney homogenates from tcpC knockout CFT073 (TcpC‑/‑) models. In vitro, TcpCwt dose‑dependently promoted MIP‑2 secretion in HEK‑293 cells. The concentration of MIP‑2 in culture supernatants of HEK‑293 co‑cultured with TcpCwt was profoundly higher compared with that of HEK‑293 co‑cultured with TcpC‑/‑. In the presence of anti‑TcpC antibody, the enhancement effect of TcpCwt on MIP‑2 production was completely abrogated, suggesting that the enhanced production of MIP‑2 was mediated by secreted TcpC. Furthermore, it was demonstrated that TcpC‑/‑ treatment had no effect on the p38 mitogen activated protein kinase (MAPK) signaling pathway, while TcpCwt treatment resulted in the activation of p38 MAPK in HEK‑293 cells, as indicated by a simultaneous increase in p38 and phosphorylated‑p38. In addition, inhibition of p38 MAPK with SB203580 significantly decreased MIP‑2 concentration and neutrophil recruitment activity in the supernatants of HEK‑293 cells co‑cultured with TcpCwt. This indicates that TcpC may promote MIP‑2 production in kidney cells through the p38 MAPK signaling pathway. Taken together, the data of the present study demonstrated that TcpC can induce MIP‑2 production, which may contribute to the characteristic histological change associated with pyelonephritis. This data has provided novel evidence to further clarify the pathogenesis of pyelonephritis and novel directions on the pathogenicity of TcpC‑secreting UPEC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Pinson AG, Philbrick JT, Lindbeck GH and Schorling JB: Oral antibiotic therapy for acute pyelonephritis: A methodologic review of the literature. J Gen Intern Med. 7:544–553. 1992. View Article : Google Scholar : PubMed/NCBI

2 

Tambo M, Okegawa T, Shishido T, Higashihara E and Nutahara K: Predictors of septic shock in obstructive acute pyelonephritis. World J Urol. 32:803–811. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Foxman B: Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis Mon. 49:53–70. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Haraoka M, Hang L, Frendéus B, Godaly G, Burdick M, Strieter R and Svanborg C: Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis. 180:1220–1229. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Bhansali RS, Yeltiwar RK and Bhat KG: Assessment of peripheral neutrophil functions in patients with localized aggressive periodontitis in the Indian population. J Indian Soc Periodontol. 17:731–736. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Hang L, Frendeus B, Godaly G and Svanborg C: Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis. 182:1738–1748. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Montecucco F, Lenglet S, Braunersreuther V, Godaly G, Burdick M, Strieter R and Svanborg C: Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. Arterioscler Thromb Vasc Biol. 30:1371–1377. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Driscoll KE, Hassenbein DG, Howard BW, Isfort RJ, Cody D, Tindal MH, Suchanek M and Carter JM: Cloning, expression, and functional characterization of rat MIP-2: A neutrophil chemoattractant and epithelial cell mitogen. J Leukoc Biol. 58:359–364. 1995.PubMed/NCBI

9 

Driscoll KE: TNFalpha and MIP-2: Role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett. 112–113:177–183. 2000. View Article : Google Scholar

10 

Tittel AP, Heuser C, Ohliger C, Knolle PA, Engel DR and Kurts C: Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol. 22:1435–1441. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Huang YY, Xia MZ, Wang H, Liu XJ, Hu YF, Chen YH, Zhang C and Xu DX: Cadmium selectively induces MIP-2 and COX-2 through PTEN-mediated Akt activation in RAW264.7 cells. Toxicol Sci. 138:310–321. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Tateno N, Matsumoto N, Motowaki T, Suzuki K and Aratani Y: Myeloperoxidase deficiency induces MIP-2 production via ERK activation in zymosan-stimulated mouse neutrophils. Free Radic Res. 47:376–385. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Janssens S and Beyaert R: Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell. 11:293–302. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Marumo S, Hoshino Y, Kiyokawa H, Tanabe N, Sato A, Ogawa E, Muro S, Hirai T and Mishima M: p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice. BMC Pulm Med. 14:792014. View Article : Google Scholar : PubMed/NCBI

15 

Schnyder-Candrian S, Quesniaux VF, Di Padova F, Maillet I, Noulin N, Couillin I, Moser R, Erard F, Vargaftig BB, Ryffel B and Schnyder B: Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J Immunol. 175:262–269. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Tarchouna M, Ferjani A, Ben-Selma W and Boukadida J: Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. Int J Infect Dis. 17:e450–e453. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Blum-Oehler G, Dobrindt U, Janke B, Nagy G, Piechaczek K and Hacker J: Pathogenicity islands of uropathogenic E. coli and evolution of virulence. Adv Exp Med Biol. 485:25–32. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Derakhshandeh A, Firouzi R, Motamedifar M, Boroojeni A Motamedi, Bahadori M, Arabshahi S, Novinrooz A and Heidari S: Distribution of virulence genes and multiple drug-resistant patterns amongst different phylogenetic groups of uropathogenic Escherichia coli isolated from patients with urinary tract infection. Lett Appl Microbiol. 60:148–154. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, et al: Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med. 14:399–406. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Snyder GA, Cirl C, Jiang J, Chen K, Waldhuber A, Smith P, Römmler F, Snyder N, Fresquez T, Dürr S, et al: Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli. Proc Natl Acad Sci USA. 110:6985–6990. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Yadav M, Zhang J, Fischer H, Huang W, Lutay N, Cirl C, Lum J, Miethke T and Svanborg C: Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 6:e10011202010. View Article : Google Scholar : PubMed/NCBI

22 

Waldhuber A, Puthia M, Wieser A, Cirl C, Dürr S, Neumann-Pfeifer S, Albrecht S, Römmler F, Müller T, Zheng Y, et al: Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation. J Clin Invest. 126:2425–2436. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Zhang C, Zhou JL, Fang J, Zhang DY, Wang BM, Chen RL and Pan JP: TcpC induces apoptosis of human vascular endothelial cells and its mechanisms. Zhejiang Da Xue Xue Bao Yi Xue Ban. 42:492–497. 2013.(In Chinese). PubMed/NCBI

24 

Zhang DY, Lin YQ, He F, Fang J, Zhang C, Wang BM and Pan JP: TcpC induces apoptosis of macrophages through promoting ROS production. Zhejiang Da Xue Xue Bao Yi Xue Ban. 42:486–491. 2013.(In Chinese). PubMed/NCBI

25 

Cox G: Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol. 154:4719–4725. 1995.PubMed/NCBI

26 

Ragnarsdóttir B and Svanborg C: Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: Host-pathogen interaction in urinary tract infections. Pediatr Nephrol. 27:2017–2029. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, et al: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Clin Infect Dis. 52:e103–e120. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Smith JA: Neutrophils, host defense, and inflammation: A double-edged sword. J Leukoc Biol. 56:672–686. 1994.PubMed/NCBI

29 

Segal AW: How neutrophils kill microbes. Annu Rev Immunol. 23:197–223. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Svensson M, Irjala H, Svanborg C and Godaly G: Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int. 74:81–90. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Ng LG, Qin JS, Roediger B, Wang Y, Jain R, Cavanagh LL, Smith AL, Jones CA, de Veer M, Grimbaldeston MA, et al: Visualizing the neutrophil response to sterile tissue injury in mouse dermis reveals a three-phase cascade of events. J Invest Dermatol. 131:2058–2068. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Sadik CD, Kim ND and Luster AD: Neutrophils cascading their way to inflammation. Trends Immunol. 32:452–460. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP and Ward PA: Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol. 158:3439–3448. 1997.PubMed/NCBI

34 

Aratani Y, Miura N, Ohno N and Suzuki K: Role of neutrophil-derived reactive oxygen species in host defense and inflammation. Med Mycol J. 53:123–128. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI

35 

Armstrong DA, Major JA, Chudyk A and Hamilton TA: Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol. 75:641–648. 2004. View Article : Google Scholar : PubMed/NCBI

36 

Hang L, Haraoka M, Agace WW, Leffler H, Burdick M, Strieter R and Svanborg C: Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. J Immunol. 162:3037–3044. 1999.PubMed/NCBI

37 

Kurosaka K, Takahashi M and Kobayashi Y: Activation of extracellular signal-regulated kinase 1/2 is involved in production of CXC-chemokine by macrophages during phagocytosis of late apoptotic cells. Biochem Biophys Res Commun. 306:1070–1074. 2003. View Article : Google Scholar : PubMed/NCBI

38 

Kawaguchi M, Onuchic LF and Huang SK: Activation of extracellular signal-regulated kinase (ERK)1/2, but not p38 and c-Jun N-terminal kinase, is involved in signaling of a novel cytokine, ML-1. J Biol Chem. 277:15229–15232. 2002. View Article : Google Scholar : PubMed/NCBI

39 

Heit B, Liu L, Colarusso P, Puri KD and Kubes P: PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. J Cell Sci. 121:205–214. 2008. View Article : Google Scholar : PubMed/NCBI

40 

Zampetaki A, Mitsialis SA, Pfeilschifter J and Kourembanas S: Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: The prominent role of p42/p44 and PI3 kinase pathways. FASEB J. 18:1090–1092. 2004.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
He Y, Fang J, Zhang C, Pan J, Jin Q, Yang Y, Wang L, Wang B, Zhang D, Pan J, Pan J, et al: TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway. Mol Med Rep 16: 3528-3534, 2017.
APA
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y. ... Pan, J. (2017). TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway. Molecular Medicine Reports, 16, 3528-3534. https://doi.org/10.3892/mmr.2017.7021
MLA
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y., Wang, L., Wang, B., Zhang, D., Pan, J."TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway". Molecular Medicine Reports 16.3 (2017): 3528-3534.
Chicago
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y., Wang, L., Wang, B., Zhang, D., Pan, J."TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway". Molecular Medicine Reports 16, no. 3 (2017): 3528-3534. https://doi.org/10.3892/mmr.2017.7021
Copy and paste a formatted citation
x
Spandidos Publications style
He Y, Fang J, Zhang C, Pan J, Jin Q, Yang Y, Wang L, Wang B, Zhang D, Pan J, Pan J, et al: TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway. Mol Med Rep 16: 3528-3534, 2017.
APA
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y. ... Pan, J. (2017). TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway. Molecular Medicine Reports, 16, 3528-3534. https://doi.org/10.3892/mmr.2017.7021
MLA
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y., Wang, L., Wang, B., Zhang, D., Pan, J."TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway". Molecular Medicine Reports 16.3 (2017): 3528-3534.
Chicago
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y., Wang, L., Wang, B., Zhang, D., Pan, J."TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway". Molecular Medicine Reports 16, no. 3 (2017): 3528-3534. https://doi.org/10.3892/mmr.2017.7021
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team